{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:40:05Z","timestamp":1789731605682,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1136\/ijgc-2021-003190","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:16:18Z","timestamp":1642760178000},"page":"753-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prospective non-interventional BELOVA\/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct02393898","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02393898","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-8981","authenticated-orcid":false,"given":"Ignace","family":"Vergote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Van Nieuwenhuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Vulsteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lamot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Van den Bulck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pascale","family":"Graas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Debrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Spoormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vuylsteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Honhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"De Maeseneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Mebis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Martinez Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Pelgrims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Van Steenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Gennigens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-003190_bb0010","unstructured":"ECIS . Estimates of cancer incidence and mortality in 2020 for all cancer sites. Available: https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-0$1-AE27$2-All$4-2$3-All$6-0,85$5-2008,2008$7-8$CEstByCancer$X0_8-3$CEstRelativeCanc$X1_8-3$X1_9-AE27"},{"key":"10.1136\/ijgc-2021-003190_bb0015","unstructured":"EUROSTAT . Causes of death - deaths by country of residence and occurrence. Available: https:\/\/appsso.eurostat.ec.europa.eu\/nui\/show.do?dataset=hlth_cd_aro&lang=en"},{"key":"10.1136\/ijgc-2021-003190_bb0020","author":"Belgian Cancer Registry","year":"2017","journal-title":"Cancer Fact Sheet: Ovarian Cancer ICD10: C56 - Belgium"},{"key":"10.1136\/ijgc-2021-003190_bb0025","first-page":"169","article-title":"Ovarian cancer: be alert to the symptoms and give women a fighting chance","volume":"19","author":"Tate","year":"2009","journal-title":"J Fam Health Care"},{"key":"10.1136\/ijgc-2021-003190_bb0030","unstructured":"Belgian Cancer Registry . The Belgian cancer registry registers data. Available: https:\/\/kankerregister.org\/Figures"},{"key":"10.1136\/ijgc-2021-003190_bb0035","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-003190_bb0040","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-003190_bb0045","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ejca.2010.02.022","article-title":"EORTC elderly Task force position paper: approach to the older cancer patient","volume":"46","author":"Pallis","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2021-003190_bb0050","unstructured":"SIOG . Comprehensive geriatric assessment (CgA) of the older patient with cancer. Available: https:\/\/www.siog.org\/content\/comprehensive-geriatric-assessment-cga-older-patient-cancer"},{"key":"10.1136\/ijgc-2021-003190_bb0055","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003190_bb0060","unstructured":"Avastin summary of product characteristics (updated 11\/03\/2020) . Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/avastin"},{"key":"10.1136\/ijgc-2021-003190_bb0065","unstructured":"RIZIV-INAMI. K.B. 01.02.2018 - IV - 6830100 Paragraaf 6830100 . Available: https:\/\/ondpanon.riziv.fgov.be\/SSPWebApplicationPublic\/nl\/Public\/ProductSearch"},{"key":"10.1136\/ijgc-2021-003190_bb0070","unstructured":"NIH . Common terminology criteria for adverse events (CTCAE) v4.0. Available: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40"},{"key":"10.1136\/ijgc-2021-003190_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.2013.51.1345","article-title":"Performance of two geriatric screening tools in older patients with cancer","volume":"32","author":"Kenis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003190_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JOP.2017.026435","article-title":"What every oncologist should know about geriatric assessment for older patients with cancer: Young International Society of Geriatric Oncology position paper","volume":"14","author":"Loh","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1136\/ijgc-2021-003190_bb0085","author":"Kenis","year":"2011","journal-title":"Practice guideline: comprehensive geriatric assessment (CgA) in oncological patients"},{"key":"10.1136\/ijgc-2021-003190_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2021-003190_bb0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/IGC.0b013e3181d3caa8","article-title":"European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies","volume":"20","author":"Vergote","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-003190_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051339","article-title":"Ovarian cancer in the elderly: time to move towards a more logical approach to improve prognosis-a study from the FRANCOGYN group","volume":"9","author":"Dion","year":"2020","journal-title":"J Clin Med"},{"key":"10.1136\/ijgc-2021-003190_bb0105","author":"Mustea","year":"2016","journal-title":"ESMO"},{"key":"10.1136\/ijgc-2021-003190_bb0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/IGC.0000000000001221","article-title":"Safety and efficacy of extended bevacizumab therapy in elderly (\u226570 years) versus younger patients treated for newly diagnosed ovarian cancer in the International ROSiA study","volume":"28","author":"Selle","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-003190_bb0115","author":"WHO","year":"2001","journal-title":"Men ageing and health achieving health across the life span"},{"key":"10.1136\/ijgc-2021-003190_bb0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/gerona\/glt162","article-title":"Heterogeneity in healthy aging","volume":"69","author":"Lowsky","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1136\/ijgc-2021-003190_bb0125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","article-title":"Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003190_bb0130","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1200\/JCO.2015.63.0319","article-title":"Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology statement","volume":"33","author":"Hurria","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-003190_bb0135","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/annonc\/mdq687","article-title":"EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors","volume":"22","author":"Pallis","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2021-003190_bb0140","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1200\/JCO.2013.49.6125","article-title":"End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article","volume":"31","author":"Wildiers","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-003190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:40:20Z","timestamp":1753224020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24010053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1048891X24010053"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-003190","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective non-interventional BELOVA\/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-003190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}